BIIB
Biogen Inc.
Stock
$222.82−3.06 (−1.35%)Close Oct 1, 2026
| Free cash flow (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $2.7B | +36.3% | −11.6% | −4.6% |
| Free cash flow (TTM) | $2.7B |
|---|---|
| YoY | +36.3% |
| 5-year CAGR | −11.6% |
| 10-year CAGR | −4.6% |
Free cash flow
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $2.1B | −24.7% |
| 2024 | $2.7B | +114.3% |
| 2023 | $1.3B | +11.0% |
| 2022 | $1.1B | −66.2% |
| 2021 | $3.4B | −11.1% |
| 2020 | $3.8B | −42.0% |
| 2019 | $6.6B | +21.2% |
| 2018 | $5.4B | +47.1% |
| 2017 | $3.7B | −7.2% |
| 2016 | $4.0B | +21.2% |
| 2015 | $3.3B | +23.4% |
| 2014 | $2.7B | +26.5% |
| 2013 | $2.1B | +29.1% |
| 2012 | $1.6B | +7.0% |
| 2011 | $1.5B | +4.7% |
| 2010 | $1.5B | +59.6% |
| 2009 | $909M | −29.3% |
| 2008 | $1.3B | +75.1% |
| 2007 | $735M | — |